A potential vaccine has brought new life to the embattled Gaithersburg biotech.
Image: Novavax CEO Stanley Erck, left, and Gregory Glenn, head of research and development, at Novavax’s office in Gaithersburg. EMAN MOHAMMED
A potential vaccine has brought new life to the embattled Gaithersburg biotech.
Image: Novavax CEO Stanley Erck, left, and Gregory Glenn, head of research and development, at Novavax’s office in Gaithersburg. EMAN MOHAMMED